Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT)

Historical Holders from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.000001 per share
Symbol
XTNT on NYSE
Shares outstanding
139,295,316
Price per share
$0.7840
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
80,064,653
Total reported value
$51,958,020
% of total 13F portfolios
0%
Share change
+101,443
Value change
+$59,666
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
29
Price from insider filings
$0.6300
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 49% 0% $50,543,166 68,394,000 0% Nantahala Capital Management, LLC 01 Aug 2025
LYTTON LAURENCE W 6.8% $4,542,452 9,463,442 Laurence W. Lytton 15 Apr 2025
As of 30 Sep 2025, Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 29 institutional shareholders filing 13F forms. They hold 80,064,653 shares. of 139,295,316 outstanding shares (57%) .

Top 25 institutional shareholders own 57% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Nantahala Capital Management, LLC 49% 68,394,000 0% 2.7% $44,380,866
AWM Investment Company, Inc. 4.7% 6,594,121 -0.04% 0.4% $4,278,925
VANGUARD GROUP INC 1.7% 2,355,671 +4.6% 0% $1,528,830
RENAISSANCE TECHNOLOGIES LLC 0.51% 713,915 +9.7% 0% $463,259
GEODE CAPITAL MANAGEMENT, LLC 0.35% 491,949 -11% 0% $319,313
Crescent Grove Advisors, LLC 0.3% 412,024 0% 0.03% $267,362
MILLENNIUM MANAGEMENT LLC 0.17% 242,924 -7.5% 0% $157,633
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.12% 164,100 0% 0% $106,484
Private Advisor Group, LLC 0.09% 123,000 0% 0% $79,815
BlackRock, Inc. 0.09% 120,326 0% 0% $78,080
Mink Brook Asset Management LLC 0.08% 109,466 0% 0.05% $71,032
CITADEL ADVISORS LLC 0.06% 80,077 +20% 0% $51,962
NORTHERN TRUST CORP 0.04% 58,666 0% 0% $38,068
HRT FINANCIAL LP 0.03% 40,803 0% $26,000
Virtu Financial LLC 0.02% 31,664 +87% 0% $21,000
STATE STREET CORP 0.02% 31,266 0% 0% $20,289
PRUDENTIAL FINANCIAL INC 0.02% 23,400 +43% 0% $15,184
Equitable Holdings, Inc. 0.02% 21,450 0% 0% $13,919
GOLDMAN SACHS GROUP INC 0.02% 21,034 0% $13,649
Petros Family Wealth, LLC 0.01% 20,000 0% 0.01% $12,978
Larson Financial Group LLC 0.01% 10,000 0% $6,489
Tower Research Capital LLC (TRC) 0% 3,570 -38% 0% $2,317
UBS Group AG 0% 394 +39300% 0% $256
BANK OF AMERICA CORP /DE/ 0% 393 -28% 0% $254
VALLEY WEALTH MANAGERS, INC. 0% 298 0% 0% $193

Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 2,000 $1,568 +$1,568 78.4% 1
2025 Q3 80,064,653 $51,958,020 +$59,666 64.89% 29
2025 Q2 79,963,210 $59,092,411 +$9,527,080 73.9% 29
2025 Q1 96,332,001 $45,274,819 -$166,227 47% 26
2024 Q4 96,692,530 $42,834,946 -$1,064,038 44.3% 28
2024 Q3 98,215,048 $66,126,833 +$5,325,340 67.6% 27
2024 Q2 90,066,890 $56,742,224 -$435,632 63% 26
2024 Q1 90,374,385 $105,738,087 +$205,479 117% 33
2023 Q4 90,202,353 $101,928,562 -$82,302 113% 31
2023 Q3 90,276,097 $99,304,130 +$9,366,353 110% 28
2023 Q2 81,765,290 $76,033,381 -$53,515 92.99% 19
2023 Q1 81,854,114 $52,181,371 -$34,628 63.75% 21
2022 Q4 81,903,507 $54,055,554 +$144,724 66% 19
2022 Q3 81,682,735 $58,794,209 +$779,674 71.94% 12
2022 Q2 80,613,065 $41,878,151 +$4,656 51.9% 12
2022 Q1 80,534,844 $54,787,198 -$46,947 68% 15
2021 Q4 80,663,007 $45,172,000 +$87,373 56.16% 17
2021 Q3 80,508,571 $89,363,000 -$2,471,600 110.73% 12
2021 Q2 82,710,575 $134,818,000 +$13,336,837 162.97% 14
2021 Q1 74,502,096 $175,824,000 +$1,768,228 235.95% 14
2020 Q4 73,761,114 $88,226,000 +$76,215,399 119.61% 11
2020 Q3 10,131,401 $8,345,000 -$186,747 82.43% 12
2020 Q2 10,345,548 $9,310,000 -$902,433 89.91% 10
2020 Q1 11,672,319 $7,820,000 +$9,453 66.84% 11
2019 Q4 11,656,858 $18,653,000 -$32,980 160% 9
2019 Q3 11,675,943 $33,159,000 -$11,600 283.93% 12
2019 Q2 11,679,733 $35,039,000 +$50,902 300% 10
2019 Q1 11,662,801 $35,571,000 -$210,500 304.99% 9
2018 Q4 11,735,030 $18,894,000 +$69,173 160.86% 11
2018 Q3 11,691,562 $45,015,000 +$2,792,758 385.32% 11
2018 Q2 10,963,855 $60,850,000 +$2,123,813 555% 12
2018 Q1 10,569,679 $83,108,926 +$83,108,926 789.03% 11